STEVE ASELAGE Insider Trading $CTIC CTI BIOPHARMA CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for STEVE ASELAGE.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of STEVE ASELAGE. STEVE ASELAGE is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and EVP, Global Commercial Ops in CTI BIOPHARMA CORP ($CTIC) and in Acer Therapeutics Inc. ($OPXA) and Director in Acer Therapeutics Inc. ($OPXA) and Chief Executive Officer in Retrophin, Inc. ($RTRX) and Director in Retrophin, Inc. ($RTRX).

STEVE ASELAGE in CTI BIOPHARMA CORP

Trading Symbol: CTIC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVE ASELAGE: EVP, Global Commercial Ops
Holdings: 6,000 shares
Current Value: $28,020
Latest Transaction: Feb 20 2004
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of STEVE ASELAGE in CTI BIOPHARMA CORP

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ACER, BCRX, CTIC, RTRX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 20 2004	CTIC	CTI BIOPHARMA CORP	ASELAGE STEVE	EVP, Global Commerc ...	Buy	P	8.90	2,000	17,800	6,000	4 K to 6 K (+50.00 %)
Feb 20 2004	CTIC	CTI BIOPHARMA CORP	ASELAGE STEVE	EVP, Global Commerc ...	Buy	P	9.00	2,000	18,000	4,000	2 K to 4 K (+100.00 %)
Feb 20 2004	CTIC	CTI BIOPHARMA CORP	ASELAGE STEVE	EVP, Global Commerc ...	Buy	P	9.10	2,000	18,200	2,000	0 to 2 K

Page: 1